Diana Kim, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1000 |
Asif N Tahir, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1061 |
Dr. Moyosore M. Suleiman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1045 Southcrest Dr Ste 200, Stockbridge, GA 30281 Phone: 678-289-0549 Fax: 678-289-8756 |
Pruthu P Patel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 404-367-3014 |
Xavier C Moore, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 147 N Park Trl, Stockbridge, GA 30281 Phone: 678-382-8091 |
News Archive
Leslie Mancuso, president and CEO of Jhpeigo, discusses public-private partnerships in the InterAction blog. "The Obama administration has recognized the importance of these relationships in the past, and we applaud any effort by the president to incentivize programming that brings together the best of the public and private sectors and the NGO community," she writes.
A pediatric patient in Marquette, Michigan is being examined by a doctor— but the doctor is 365 miles away in Ann Arbor. Elsewhere in Michigan, a mental health patient, his family and psychiatrist are participating in a commitment hearing in the safe, secure environment of a psychiatric unit— but the judge is actually on the other side of town.
Cholesterol manufactured in the brain appears to play a key role in the development of Alzheimer's disease, new research indicates.
The Institute for Quality and Efficiency in Health Care (IQWiG) revised its methods paper and published the German original version "Allgemeine Methoden 6.0" (General Methods 6.0) on http://www.iqwig.de in November 2020.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
› Verified 3 days ago